Exp Clin Endocrinol Diabetes 2020; 128(08): 499-505
DOI: 10.1055/a-0636-3883
Article

Fangchinoline Protects Against Renal Injury in Diabetic Nephropathy by Modulating the MAPK Signaling Pathway

Yingsong Jiang
1   Department of Nephrology, Chongqing General Hospital, Chongqing, China
,
Jiguo Liu
1   Department of Nephrology, Chongqing General Hospital, Chongqing, China
,
Zemei Zhou
1   Department of Nephrology, Chongqing General Hospital, Chongqing, China
,
Ke Liu
1   Department of Nephrology, Chongqing General Hospital, Chongqing, China
,
Chun Liu
1   Department of Nephrology, Chongqing General Hospital, Chongqing, China
› Author Affiliations

Abstract

In this study, we evaluated the nephroprotective effects of fangchinoline in rats with diabetic nephropathy (DN). DN was induced by feeding a high-fat diet for 4 weeks and administering a single dose of streptozotocin (STZ) (30 mg/kg) intraperitoneally. The rats were split into groups; one group received oral fangchinoline (3 mg/kg) per day for 8 weeks. After completion of the 8-week study period, biomedical and inflammatory markers were evaluated in serum and urine, and oxidative stress was estimated in kidney tissues. In addition, Western blot assays, reverse transcription-polymerase chain reaction, and immunohistochemical analyses were performed in the kidney tissues of DN rats. The results suggest that treatment with fangchinoline attenuated the biochemical marker changes induced by DN in blood and urine. Moreover, a significant (p<0.01) reduction in inflammatory markers in serum was found in the fangchinoline group compared to the controls. Immunohistochemical analyses also revealed that treatment with fangchinoline significantly reduced the expression of collagen IV and CD31 in the kidneys compared to the control group. The expression of p38 MAPK, TNF-α, COX-2, and MMP-9 was also attenuated by fangchinoline treatment in the kidney tissues of DN rats. Together, the results of this study suggest that fangchinoline protects against nephron damage by attenuating alterations in the p38 MAPK pathway, thereby reducing oxidative stress and inflammation in DN rats.



Publication History

Received: 28 March 2018
Received: 20 May 2018

Accepted: 28 May 2018

Article published online:
26 July 2018

© Georg Thieme Verlag KG
Stuttgart · New York

 
  • References

  • 1 Lim AK. Diabetic nephropathy – complications and treatment. International Journal of Nephrology and Renovascular Disease 2014; 7: 361-381
  • 2 Kolset SO, Reinholt FP, Jenssen T. Diabetic Nephropathy and Extracellular Matrix. J Histochem Cytochem 2012; 60: 976-986
  • 3 Steven D. Crowley, The Cooperative Roles of Inflammation and Oxidative Stress in the Pathogenesis of Hypertension. Antioxid Redox Signal 2014; 20: 102-120
  • 4 Wang S, Ding L, Ji H. et al. The Role of p38 MAPK in the Development of Diabetic Cardiomyopathy. Int J Mol Sci 2016; 17: 1037
  • 5 Toyoda M, Suzuki D, Honma M. et al. High expression of PKC-MAPK pathway mRNAs correlates with glomerular lesions in human diabetic nephropathy. Kidney Int 2004; 66: 1107-1114
  • 6 Cargnello M, Roux PP. Activation and Function of the MAPKs and Their Substrates, the MAPK-Activated Protein Kinases. Microbiol Mol Biol Rev 2011; 75: 50-83
  • 7 Chen P, Yuan Y, Zhang T. et al. Pentosan polysulfate ameliorates apoptosis and inflammation by suppressing activation of the p38 MAPK pathway in high glucose-treated HK-2 cells. Int J Mol Med 2018; 41: 908-914
  • 8 Xie Z, Xu X, Xie C. et al. Preparative isolation of tetrandrine and fangchinoline from Radix Stephania tetrandra using reversed-phase flash chromatography. Journal of Liquid Chromatography & Related Technologies 2013; 37: 343-352
  • 9 Tsutsumi T, Kobayashi S, Liu YY. et al. Anti-hyperglycemic effect of fangchinoline isolated from Stephania tetrandra Radix in streptozotocin-diabetic mice. Biol Pharm Bull 2003; 26: 313-317
  • 10 Liu Y, Xia B, Lan J. et al. Design, Synthesis and Anticancer Evaluation of Fangchinoline Derivatives. Molecules 2017; 8: 22
  • 11 Choi HS, Kim HS, Min KR. et al. Anti-inflammatory effects of fangchinoline and tetrandrine. J Ethnopharmacol 2000; 69: 173-179
  • 12 Pourghasem M, Shafi H, Babazadeh Z. Histological changes of kidney in diabetic nephropathy. Caspian J Intern Med 2015; 6: 120-127
  • 13 Lopez-Giacoman S, Madero M. Biomarkers in chronic kidney disease, from kidney function to kidney damage. World J Nephrol 2015; 4: 57-73
  • 14 Park IS, Kiyomoto H, Abboud SL. et al. Expression of transforming growth factor-beta and type IV collagen in early streptozotocin-induced diabetes. Diabetes 1997; 46: 473-480
  • 15 Bhatt K, Lanting LL, Jia Y. et al. Anti-Inflammatory Role of MicroRNA-146a in the Pathogenesis of Diabetic Nephropathy. Journal of the American Society of Nephrology: JASN 2016; 27: 2277-2288
  • 16 Milan Manani S, Virzì GM, Clementi A. et al. Pro-inflammatory cytokines: a possible relationship with dialytic adequacy and serum albumin in peritoneal dialysis patients. Clinical Kidney Journal 2016; 9: 153-157
  • 17 Piechota-Polanczyk A, Fichna J. Review article: The role of oxidative stress in pathogenesis and treatment of inflammatory bowel diseases. Naunyn-Schmiedeberg’s Archives of Pharmacology 2014; 387: 605-620
  • 18 Zhang L, Ji L, Tang X. et al. Inhibition to DRP1 translocation can mitigate p38 MAPK-signaling pathway activation in GMC induced by hyperglycemia. Ren Fail 2015; 37: 903-910
  • 19 Grynberg K, Ma FY, Nikolic-Paterson DJ. The JNK Signaling Pathway in Renal Fibrosis. Frontiers in Physiology 2017; 8: 829